NETWORK META-ANALYSIS OF TOFACITINIB VS BDMARDS OR APREMILAST FOR THE TREATMENT OF TNF INHIBITOR-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS

被引：2
|
作者：
Gladman, D. D. [1 ]
Orbai, A. -M. [2 ]
Gomez-Reino, J. [3 ]
Chang-Douglass, S. [4 ]
Leoncini, E. [4 ]
Burton, H. E. [4 ]
Kanik, K. S. [5 ]
Hendrikx, T. [6 ]
Cappelleri, J. C. [5 ]
Hsu, M. -A. [5 ]
机构：
[1] Univ Toronto, Toronto Western Hosp, Toronto, ON, Canada
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Hosp Clin Univ, Santiago De Compostela, Spain
[4] Decis Resources Grp, London, England
[5] Pfizer Inc, Groton, CT 06340 USA
[6] Pfizer Inc, Collegeville, PA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.4823
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0300
引用
收藏
页码：368 / 369
页数：2
相关论文
共 50 条
  • [41] Biologic Initiation Rate in Systemic-Naive Psoriatic Arthritis Patients Starting Treatment with Apremilast vs Methotrexate: 1-Year Retrospective Analysis of a US Claims Database
    Husni, M. Elaine
    Chang, Eunice
    Broder, Michael S.
    Paydar, Caleb
    Bognar, Katalin
    Desai, Pooja
    Klyachkin, Yuri
    Khilfeh, Ibrahim
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2022, 14 : 123 - 132
  • [42] Relative efficacy and safety of secukinumab and guselkumab for the treatment of active psoriatic arthritis: A network meta-analysis
    Song, Gwan Gyu
    Lee, Young Ho
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (06) : 433 - 441
  • [43] Network meta-analysis and cost per responder of targeted Immunomodulators in the treatment of active psoriatic arthritis
    Strand V.
    Elaine Husni M.
    Betts K.A.
    Song Y.
    Singh R.
    Griffith J.
    Beppu M.
    Zhao J.
    Ganguli A.
    BMC Rheumatology, 2 (1)
  • [44] MORTALITY IN PATIENTS WITH PSORIATIC ARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Huang, H.
    Xie, W.
    Geng, Y.
    Fan, Y.
    Zhang, Z.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1798 - 1799
  • [45] Network meta-analysis of tofacitinib versus biologic treatments in moderate-to-severe rheumatoid arthritis patients
    Camean-Castillo, Manuel
    Gimeno-Ballester, Vicente
    Rios-Sanchez, Esmeralda
    Fenix-Caballero, Silvia
    Vazquez-Real, Miguel
    Alegre-del Rey, Emilio
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, 44 (03) : 384 - 396
  • [46] A NETWORK META-ANALYSIS OF BIOLOGIC TREATMENTS IN TNF-IR RHEUMATOID ARTHRITIS PATIENTS
    LeReun, C.
    Neophytou, I
    De Vries, R.
    Diamantopoulos, A.
    Pompen, M.
    VALUE IN HEALTH, 2011, 14 (07) : A303 - A303
  • [47] COST AND COST PER RESPONDER IN SPAIN OF ADALIMUMAB, METHOTREXATE AND APREMILAST IN THE TREATMENT OF METHOTREXATE-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS
    Morell, A.
    Ramirez, E.
    Llorente, I
    Garcia-Vicuna, R.
    Blasco, A. J.
    VALUE IN HEALTH, 2016, 19 (07) : A540 - A540
  • [48] Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis
    Thorlund, Kristian
    Druyts, Eric
    Avina-Zubieta, J. Antonio
    Mills, Edward J.
    BIOLOGICS-TARGETS & THERAPY, 2012, 6 : 417 - 427
  • [49] Treatment of psoriatic arthritis with anti-TNF agents: a systematic review and meta-analysis of efficacy, effectiveness and safety
    Lívia Lovato Pires Lemos
    Juliana de Oliveira Costa
    Alessandra Maciel Almeida
    Haliton Oliveira Junior
    Mariana Michel Barbosa
    Adriana Maria Kakehasi
    Francisco Assis Acurcio
    Rheumatology International, 2014, 34 : 1345 - 1360
  • [50] Treatment of psoriatic arthritis with anti-TNF agents: a systematic review and meta-analysis of efficacy, effectiveness and safety
    Pires Lemos, Livia Lovato
    Costa, Juliana de Oliveira
    Almeida, Alessandra Maciel
    Oliveira Junior, Haliton
    Barbosa, Mariana Michel
    Kakehasi, Adriana Maria
    Acurcio, Francisco Assis
    RHEUMATOLOGY INTERNATIONAL, 2014, 34 (10) : 1345 - 1360
12345